Articles

Low dose Btk inhibitors selectively block platelet activation by CLEC-2

Institute of Cardiovascular Sciences, University of Birmingham, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Universities of Birmingham and Nottingham, Midlands, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Universities of Birmingham and Nottingham, Midlands, UK;
Universities of Birmingham and Nottingham, Midlands, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Department of Immunology, Heartlands Hospital, Birmingham, UK;
Department of Immunology, Heartlands Hospital, Birmingham, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, UK;
Institute for Physiological Chemistry & Pathobiochemistry, University of Münster, Germany;
Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK
Universities of Birmingham and Nottingham, Midlands, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, UK;
Haematologica Early view Jan 16, 2020 https://doi.org/10.3324/haematol.2019.218545